Operating Expenses Summary of Medistim ASA

Medistim ASA's latest annual operating expenses in 2023 was 277.38 Million NOK , down -59.59% from previous year.
Medistim ASA's latest quarterly operating expenses in 2024 Q3 was 74.68 Million NOK , down -19.03% from previous quarter.
Medistim ASA reported a annual operating expenses of 238.52 Million NOK in annual operating expenses 2022, up 16.68% from previous year.
Medistim ASA reported a annual operating expenses of 204.42 Million NOK in annual operating expenses 2021, up 11.01% from previous year.
Medistim ASA reported a quarterly operating expenses of 74.68 Million NOK for 2024 Q3, down -19.03% from previous quarter.
Medistim ASA reported a quarterly operating expenses of 24.33 Million NOK for 2024 Q1, down -6.94% from previous quarter.

Annual Operating Expenses Chart of Medistim ASA (2023 - 2004)

Historical Annual Operating Expenses of Medistim ASA (2023 - 2004)

Year	Operating Expenses	Operating Expenses Growth
2023	277.38 Million NOK	-59.59%
2022	238.52 Million NOK	16.68%
2021	204.42 Million NOK	11.01%
2020	184.14 Million NOK	-1.53%
2019	187 Million NOK	10.23%
2018	169.65 Million NOK	7.51%
2017	157.8 Million NOK	11.63%
2016	141.36 Million NOK	6.84%
2015	132.31 Million NOK	14.74%
2014	115.31 Million NOK	9.27%
2013	105.53 Million NOK	15.46%
2012	91.4 Million NOK	-2.26%
2011	93.51 Million NOK	4.11%
2010	89.82 Million NOK	4.99%
2009	85.55 Million NOK	13.6%
2008	75.31 Million NOK	9.32%
2007	68.89 Million NOK	5273.71%
2006	1.28 Million NOK	1.83%
2005	1.25 Million NOK	48.29%
2004	849 Thousand NOK	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	28.43 Million NOK	16.87%
2024 Q3	74.68 Million NOK	-19.03%
2024 Q1	24.33 Million NOK	-6.94%
2023 FY	96.38 Million NOK	-59.59%
2023 Q3	68.23 Million NOK	4.53%
2023 Q4	26.14 Million NOK	-61.68%
2023 Q1	69.9 Million NOK	4.49%
2023 Q2	65.27 Million NOK	-6.63%
2022 Q1	59.02 Million NOK	5.52%
2022 Q3	60.58 Million NOK	16.47%
2022 Q4	66.9 Million NOK	10.44%
2022 FY	238.52 Million NOK	16.68%
2022 Q2	52.01 Million NOK	-11.88%
2021 Q4	55.93 Million NOK	5.01%
2021 FY	204.42 Million NOK	11.01%
2021 Q2	44.45 Million NOK	-12.43%
2021 Q1	50.76 Million NOK	18.35%
2021 Q3	53.26 Million NOK	19.82%
2020 FY	184.14 Million NOK	-1.53%
2020 Q1	55.24 Million NOK	12.12%
2020 Q2	38.88 Million NOK	-29.63%
2020 Q3	47.12 Million NOK	21.21%
2020 Q4	42.89 Million NOK	-8.99%
2019 Q1	48.09 Million NOK	3.91%
2019 Q2	41.75 Million NOK	-13.18%
2019 FY	187 Million NOK	10.23%
2019 Q4	49.27 Million NOK	2.92%
2019 Q3	47.87 Million NOK	14.65%
2018 Q4	46.29 Million NOK	11.32%
2018 Q2	39.48 Million NOK	-6.63%
2018 Q1	42.29 Million NOK	6.05%
2018 FY	169.65 Million NOK	7.51%
2018 Q3	41.58 Million NOK	5.3%
2017 Q4	39.87 Million NOK	-2.6%
2017 Q2	36.52 Million NOK	-9.73%
2017 FY	157.8 Million NOK	11.63%
2017 Q3	40.94 Million NOK	12.11%
2017 Q1	40.45 Million NOK	13.12%
2016 Q1	36.27 Million NOK	-3.36%
2016 FY	141.36 Million NOK	6.84%
2016 Q4	35.76 Million NOK	-2.08%
2016 Q3	36.52 Million NOK	11.41%
2016 Q2	32.78 Million NOK	-9.61%
2015 Q1	31.05 Million NOK	-7.7%
2015 FY	132.31 Million NOK	14.74%
2015 Q4	37.53 Million NOK	6.66%
2015 Q3	35.19 Million NOK	23.36%
2015 Q2	28.52 Million NOK	-8.15%
2014 FY	115.31 Million NOK	9.27%
2014 Q4	33.65 Million NOK	15.48%
2014 Q3	29.13 Million NOK	22.05%
2014 Q2	23.87 Million NOK	-16.69%
2014 Q1	28.65 Million NOK	0.38%
2013 Q4	28.54 Million NOK	8.71%
2013 Q3	26.26 Million NOK	6.31%
2013 FY	105.53 Million NOK	15.46%
2013 Q2	24.7 Million NOK	-5.1%
2013 Q1	26.02 Million NOK	-7.66%
2012 Q2	22.31 Million NOK	-10.08%
2012 Q3	16.08 Million NOK	-27.93%
2012 Q4	28.18 Million NOK	75.27%
2012 FY	91.4 Million NOK	-2.26%
2012 Q1	24.81 Million NOK	5.83%
2011 Q4	23.44 Million NOK	2.36%
2011 FY	93.51 Million NOK	4.11%
2011 Q2	22.58 Million NOK	-8.11%
2011 Q3	22.9 Million NOK	1.44%
2011 Q1	24.57 Million NOK	1.81%
2010 FY	89.82 Million NOK	4.99%
2010 Q4	24.14 Million NOK	4.77%
2010 Q3	23.04 Million NOK	19.21%
2010 Q2	19.32 Million NOK	-17.08%
2010 Q1	23.31 Million NOK	-3.76%
2009 Q2	18.56 Million NOK	-15.11%
2009 Q1	21.86 Million NOK	0.0%
2009 FY	85.55 Million NOK	13.6%
2009 Q4	24.22 Million NOK	15.88%
2009 Q3	20.9 Million NOK	12.59%
2008 FY	75.31 Million NOK	9.32%
2007 FY	68.89 Million NOK	5273.71%
2006 FY	1.28 Million NOK	1.83%
2005 FY	1.25 Million NOK	48.29%
2004 FY	849 Thousand NOK	0.0%

Peer Operating Expenses Comparison of Medistim ASA

Name	Operating Expenses	Operating Expenses Difference
Gentian Diagnostics ASA	88.35 Million NOK	-213.935%
Lifecare AS	45.18 Million NOK	-513.944%

Global Stocks Search

Medistim ASA (MEDI.OL)

Operating Expenses Summary of Medistim ASA

Annual Operating Expenses Chart of Medistim ASA (2023 - 2004)

Historical Annual Operating Expenses of Medistim ASA (2023 - 2004)

Peer Operating Expenses Comparison of Medistim ASA